CHRISTOPHER BUNKA - 07 May 2021 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
CEO, Director
Signature
/Chris Bunka/
Issuer symbol
LEXX
Transactions as of
07 May 2021
Net transactions value
$0
Form type
4
Filing time
09 Jun 2021, 12:48:45 UTC
Next filing
09 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 215,912 07 May 2021 Private Holding Company
holding LEXX common shares 273,543 07 May 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Other $0 -23,334 -42% $0.000000 32,667 07 May 2021 Common Shares 23,334 $10.20 Direct F1
holding LEXX Warrants 6,667 07 May 2021 Common Shares 6,667 $10.50 Private Holding Company
holding LEXX Stock Options 30,001 07 May 2021 Common Shares 23,334 $10.20 Direct
holding LEXX Stock Options 56,001 07 May 2021 Common Shares 26,000 $5.83 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Cancelled Options